Amdocs (NASDAQ:DOX) Releases FY25 Earnings Guidance

Amdocs (NASDAQ:DOX) updated its FY25 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of $6.86-7.12 for the period, compared to the consensus estimate of $7.03. The company issued revenue guidance of $4.46-4.62 billion, compared to the consensus revenue estimate of $5.17 billion. Amdocs also updated its FY 2025 guidance to 6.859-7.116 EPS.

Amdocs Price Performance

NASDAQ DOX traded down $0.13 during trading hours on Friday, hitting $85.58. 11,631 shares of the company’s stock traded hands, compared to its average volume of 678,970. The company has a market capitalization of $10.06 billion, a PE ratio of 20.21, a PEG ratio of 1.42 and a beta of 0.74. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.24 and a quick ratio of 1.24. Amdocs has a 52-week low of $74.41 and a 52-week high of $94.04. The firm’s 50-day moving average is $88.18 and its 200-day moving average is $83.94.

Amdocs Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.479 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.24%. Amdocs’s dividend payout ratio (DPR) is presently 45.28%.

Analysts Set New Price Targets

A number of brokerages have issued reports on DOX. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Barclays decreased their target price on shares of Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a report on Thursday. Oppenheimer raised their price target on shares of Amdocs from $98.00 to $105.00 and gave the stock an “outperform” rating in a report on Wednesday. Finally, Stifel Nicolaus initiated coverage on Amdocs in a report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price objective on the stock. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Amdocs presently has an average rating of “Moderate Buy” and an average target price of $101.83.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.